Home » Topics » Regulatory

Regulatory
RSS

Zanitek receives German approval

July 28, 2006

Oncaspar approved in first-line treatment for ALL

July 26, 2006

Elaprase approved for Hunter's syndrome

July 25, 2006

German approval for new phosphate binding agent OsvaRen

July 25, 2006

Mycophenolate mofetil approved in Malaysia for lupus nephritis

July 20, 2006

FDA approves Atripla, first once-daily single tablet regimen for HIV

July 13, 2006

FDA approves Emend for prevention of postoperative nausea and vomiting

July 12, 2006

Avandamet approved for initial treatment of type 2 diabetes

July 12, 2006

Revlimid approved for use in multiple myeloma

June 30, 2006

Sprycel approved for two new indications

June 29, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...